Results 261 to 270 of about 521,718 (340)
A series of 14 novel 1,4‐benzoxazinone derivatives is tested against various strains of Mycobacterium tuberculosis. All compounds show high activity against all tested strains, particularly the resistant strains. Additionally, the novel derivatives exhibit low cytotoxicity toward mammalian Vero cells.
Maria Grazia Mamolo+6 more
wiley +1 more source
Studies on Dihydrofolic Reductase
Bernard T. Kaufman, Rita C. Gardiner
openalex +1 more source
Is Mycobacterial InhA a Suitable Target for Rational Drug Design?
InhA is the target of isoniazid, a first‐line antituberculosis drug. Isoniazid is, in fact, a prodrug that needs to be activated. Researchers are trying to develop direct inhibitors of InhA. This includes the resolution of crystallographic structures. The Protein Data Bank contains over a hundred InhA structures.
Julien Rizet+7 more
wiley +1 more source
Release of Repressor Control of Ribonucleotide Reductase by Thymine Starvation
Chitra Biswas+2 more
openalex +1 more source
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
T. Lancet+10 more
semanticscholar +1 more source
Quinazolinone‐based compounds emerge as potent antimycobacterial agents, showing low minimum inhibitory concentrations against drug‐resistant Mycobacterium tuberculosis. Molecular modeling uncovers a novel allosteric site in PonA1 targeted by these derivatives.
Marek Kerda+15 more
wiley +1 more source
Dihydrofolate Reductase of Streptococcus faecium
Peter F. Nixon, Raymond L. Blakley
openalex +1 more source
Gold nanoparticles (AuNPs) are widely used in biomedicine, electronics, catalysis, and environmental science. Conventional synthesis relies on harsh chemicals, driving interest in eco‐friendly methods using plants, bacteria, fungi, and algae. Biomolecules like polyphenols, proteins, and fatty acids aid nanoparticle synthesis under mild conditions. This
Youfeng Yue+3 more
wiley +1 more source